Naturally occurring phenylethanoids and phenylpropanoids: antimalarial potential

Malaria as an infectious disease is one of the world's most dangerous parasitic diseases. There is an urgent need for the development of new antimalarial drugs. Natural products are a very rich source of new bioactive compounds. Our research aims to shed light on the recent studies which demonstrated the antimalarial potential of phenylpropanoids as a major natural-products class. This study involves an in silico analysis of naturally-occurring phenylpropanoids and phenylethanoids which showed 25 compounds with moderate to strong binding affinity to various amino acid residues lining the active site; P. falciparum kinase (PfPK5), P. falciparum cytochrome bc1 complex (cyt bc1), and P. falciparum lysyl-tRNA synthetase (PfKRS1); of Plasmodium falciparum parasite, a unicellular protozoan which causes the most severe and life-threatening malaria. Furthermore, the study was augmented by the assessment of antiplasmodial activity of glandularin, a naturally occurring dibenzylbutyrolactolic lignan, against chloroquine-sensitive 3D7 strain of P. falciparum using SYBR green I-based fluorescence assay, which showed high antimalarial activity with IC50 value of 11.2 & mu;M after 24 hours of incubation. Our results highlight phenylpropanoids and glandularin in particular as a promising chemical lead for development of antimalarial drugs. Naturally occurring phenylethanoids and phenylpropanoids were assessed for antimalarial potential using in silico and in vitro studies.

Automated summary

Malaria is a dangerous parasitic disease, and new antimalarial drugs are urgently needed. Natural products, particularly phenylpropanoids, have shown potential as antimalarial agents. In this study, in silico analysis and in vitro assays were conducted to assess the antimalarial activity of naturally-occurring phenylpropanoids.